Raised cerebrospinal fluid nitrite and nitrate levels in patients with multiple sclerosis: no correlation with disease activity

Abstract

A growing body of evidence implicates excessive generation of nitric oxide (NO) within the central nervous system (CNS) in multiple sclerosis (MS). The aim of our study is to analyse nitrite and nitrate as end products of NO in the cerebrospinal fluid (CSF) from MS patients and correlate the concentrations with clinical characteristics of the disease. CSF nitrite and nitrate concentrations were measured after reduction of nitrate, by Griess reaction, in 105 MS patients, 27 patients with non-inflammatory neurological disorders (NIND) and 13 individuals without neurological disorder (Co). Mean CSF nitrite and nitrate concentrations were significantly higher in patients with MS and NIND compared with the Co patients (9.44 and 8.68, respectively, versus 6.85 μM; P=0.0001 and P=0.031, respectively). There was no significant correlation between CSF nitrite and nitrate concentrations and activity, phase, severity and duration of MS. Our data are in agreement with the results of previous studies which have demonstrated raised concentrations of CSF NO metabolites in MS patients, providing further evidence for NO involvement in MS. The lack of correlation between NO metabolites and disease activity speaks in favour of the possible dual role of NO, as both immunoregulatory and proinflammatory molecule, in the pathogenesis of MS.

Keywords

multiple sclerosis nitric oxide cerebrospinal fluid magnetic resonance imaging disease activity brain tumour

Get full access to this article

View all access options for this article.

References

Nathan C. (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100: 2417-2423 .

Bagasra O et al. (1995) Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis . Proc Natl Acad Sci USA 92: 12041-12045 .

DeGroot CJ et al. (1997) Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions . J Neuropathol Exp Neurol 56: 10-20 .

Oleszak EL et al. (1998) Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis . Clin Diagn Lab Immunol 5: 438-445 .

Yamashita T et al. (1997) Changes in nitrite and nitrate (NO2−/NO3−) levels in cerebrospinal fluid of patients with multiple sclerosis . J Neurol Sci 153: 32-34 .

Giovannoni G. (1998) Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis . Mult Scler 4: 27-30 .

Koprowski H et al. (1993) In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases . Proc Natl Acad Sci USA 90: 3024-3027 .

Zhang J , Cross AH , McCarthy TJ , Welch MJ. (1997) Measurement of upregulation of inducible nitric oxide synthase in the experimental autoimmune encephalomyelitis model using a positron emitting radiopharmaceutical . Nitric Oxide 1: 263-267 .

Cross AH et al. (1994) Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice . J Clin Invest 93: 2684-2690 .

10.

Ding M et al. (1998) Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice . J Immunol 160: 2560-2564 .

11.

Ruuls SR et al. (1996) Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors . Clin Exp Immunol 103: 467-474 .

12.

Fenyk-Melody JE et al. (1998) Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene . J Immunol 160: 2940-2946 .

13.

Kolb H , Kolb-Bachofen V. (1998) Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 19: 556-561 .

14.

Poser CM et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols . Ann Neurol 13: 27-31 .

15.

Kurtzke JF. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) . Neurology 33: 1444-1452 .

16.

Giovannoni G et al. (1997) Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels . Ann Clin Biochem 34: 193-198 .

17.

Johnson AW et al. (1995) Evidence for increased nitric oxide production in multiple sclerosis . J Neurol Neurosurg Psychiatry 58: 107-115 .

18.

Cross AH et al. (1998) Peroxynitrite formation within the central nervous system in active multiple sclerosis . J Neuroimmunol 88: 45-56 .

19.

Brundin L et al. (1999) Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker . Eur J Neurology 6: 585-590 .

20.

Svenningsson A , Petersson A-S , Andersen O , Hansson GK. (1999) Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course . Neurology 53: 1880-1882 .

21.

Mitrovic B et al. (1994) Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro . Neuroscience 61: 575-585 .

22.

Smith KJ , Kapoor R , Hall SM , Davies M. (1998) Nitric oxide donors cause persistent axonal damage: electrically active axons are especially susceptible . Soc Neurosci Abstr 737.2-737.2 .

23.

Redford EJ , Kapoor R , Smith KJ. (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible . Brain 120: 2149-2157 .

24.

Parkinson JF , Mitrovic B , Merrill JE. (1997) The role of nitric oxide in multiple sclerosis . J Mol Med 75: 174-186 .

25.

Willenborg DO , Staykova MA , Cowden WB. (1999) Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review . J Neuroimmunol 100: 21-35 .

26.

Martinez I , Puerta C , Redondo C , Garcia-Merino A. (1999) Type IV phosphodiesterase inhibition in experimental allergic encephalomyelitis of Lewis rats: sequential gene expression analysis of cytokines, adhesion molecules and the inducible nitric oxide synthase . J Neurol Sci 164: 13-23 .

27.

Kuschnaroff LM et al. (1999) Effect of staphylococcal enterotoxin B injection on the development of experimental autoimmune encephalomyelitis: influence of cytokine and inducible nitric oxide synthase production . J Neuroimmunol 99: 157-168 .

28.

Cowden WB , Cullen FA , Staykova MA , Willenborg DO. (1998) Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE . J Neuroimmunol 88: 1-8 .

29.

Xu L et al. (1999) Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats . Clin Exp Immunol 118: 115-121 .